However, research into the Second Meal Effect suggests that eating high-fiber prebiotics at breakfast can improve your satiety and GLP-1 response for the rest of the day
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), initially developed for type 2 diabetes management, have demonstrated remarkable efficacy in addressing the multifactorial pathogenesis of MASLD/MASH [7-10]
the relevance of these findings to humans is currently unknown, and no causal link has been established in human trials to date
These medications mimic the natural actions of GLP-1, improving insulin secretion, enhancing glucose management, and promoting weight loss in patients with type 2 diabetes or obesity
Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A
Noom was previously offering microdoses of compounded GLP-1 semaglutide for weight loss for people with a BMI of 25 or higher